How blood cancer research is decoding the hidden mechanics of aging and disease

How blood cancer research is decoding the hidden mechanics of aging and disease
Image: Intellect (generated)

In short: Professor George Vassiliou is a leading haematologist at the University of Cambridge, dedicated to unraveling the origins of myeloid malignancies. By studying how normal stem cells transform into leukaemic ones, his team identifies genetic vulnerabilities and develops innovative therapeutic approaches to detect and prevent blood cancers before they fully manifest.

Professor George Vassiliou, a Consultant Haematologist at Cambridge University Hospitals and Professor of Haematological Medicine at the University of Cambridge, has spent his career investigating the pathogenesis of acute myeloid leukaemia (AML) and related blood cancers. Born in Cyprus and trained in London and Cambridge, he earned his PhD in 2005. In 2011, he established his research team at the Wellcome Sanger Institute, later moving his laboratory to the Cambridge Stem Cell Institute in 2019.

His research group employs a multifaceted approach to understand the transformation of haemopoietic stem cells. They utilize genetic screens to uncover vulnerabilities in myeloid malignancies, create bespoke mouse models to study somatic mutation drivers, and investigate the epidemiological basis of clonal haematopoiesis (CH) in healthy individuals. This work is critical for predicting leukaemic progression and developing early detection strategies. By mapping how mutations influence cellular behavior, the team aims to transform the clinical management of myeloid diseases.

The scope of Vassiliou's work is extensive, as evidenced by his recent publications. His research explores diverse mechanisms, including the role of telomere attrition in clonal selection, the impact of specific mutations on macrophage cytokines and atherogenesis, and the influence of epigenetic factors on cancer evolution. Through collaborations, his team has also examined how clonal haematopoiesis affects microglial dynamics and how specific catalytic activities drive transcriptional activation in AML. These studies underscore the complexity of blood cancer evolution and the potential for targeted therapies to disrupt oncogenic signaling.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/society-george-vassiliou.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…